Corticosteroid Injection Series: Pharmacy Lien Documentation

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 29, 2026 | 8 min read

Corticosteroid injection series — epidural, trigger point, and joint injections — are among the most common pain management procedures in PI cases. Proper documentation of the injection timeline, clinical rationale, and outcomes strengthens both the demand package and the pharmacy lien.

Corticosteroid Injection Series: Documentation for Demand Packages

A corticosteroid injection series in a personal injury case documents injury severity, treatment necessity, and the progressive nature of pain management with objective clinical evidence that strengthens both the demand package and the pharmacy lien. Epidural steroid injections, trigger point injections, and joint injections each serve distinct clinical purposes and require specific documentation strategies.

• Corticosteroid injections document injury severity because physicians do not administer them for trivial conditions — each injection represents a clinical determination that conservative oral therapy was insufficient
• LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages
• The progression from oral medications to injectable corticosteroids demonstrates treatment escalation that quantifies injury seriousness
• According to James Wong, PharmD, founder of LienScripts, corticosteroid injection documentation is among the most powerful evidence of injury severity because it shows the treating physician determined that oral medications alone could not control the patient's pain

Types of Corticosteroid Injections in PI Cases

Epidural Steroid Injections (ESIs)

Epidural steroid injections deliver corticosteroid medication directly into the epidural space surrounding the spinal cord and nerve roots. They are prescribed for radiculopathy, disc herniation, spinal stenosis, and other conditions causing nerve root compression.

Clinical significance for the demand package: A physician who orders an ESI has determined that the patient's radicular pain is severe enough to warrant an invasive procedure. This is not a routine prescription — it requires imaging confirmation of the anatomical source, informed consent, fluoroscopic guidance, and typically a series of two to three injections spaced weeks apart.

Documentation elements:

• Pre-injection imaging (MRI or CT) identifying the anatomical pathology
• The referring physician's clinical rationale for injection therapy
• Each injection date, site, medication administered, and volume
• Post-injection follow-up documenting the degree and duration of pain relief
• Oral medications prescribed between injections (breakthrough pain management)

Trigger Point Injections (TPIs)

Trigger point injections target specific myofascial pain points — areas of muscle spasm that create referred pain patterns. They are common after motor vehicle accidents causing cervical, thoracic, and lumbar muscle injury.

Clinical significance: Trigger point injections document the physical location and severity of muscle injury. Each injection site identifies a specific area of pathology, creating a body map of the patient's injuries.

[!KEY] A series of trigger point injections at multiple anatomic sites over several visits documents the extent and persistence of musculoskeletal injury in a way that subjective pain complaints alone cannot. Each injection site is a physician-identified point of pathology.

Intra-Articular (Joint) Injections

Joint injections deliver corticosteroids directly into an affected joint — commonly the knee, shoulder, hip, or facet joints. They address inflammatory arthritis, traumatic joint injury, and post-traumatic osteoarthritis aggravation.

Clinical significance: Joint injections prove that the trauma caused or aggravated specific joint pathology. A patient who receives a shoulder joint injection after a motor vehicle accident has physician-confirmed shoulder joint inflammation or injury.

The Injection Series as a Treatment Narrative

A corticosteroid injection series tells a clinical story that strengthens the demand package:

Injection 1: The physician has exhausted oral medication options and determined that the patient's pain requires direct anti-inflammatory treatment at the injury site. This documents treatment escalation.

Injection 2 (if performed): The first injection provided temporary relief that wore off, demonstrating that the underlying pathology persists. This documents chronicity.

Injection 3 (if performed): The condition requires ongoing intervention — the injury has not resolved. At this point, the physician often discusses surgical options, further documenting severity.

[!TIP] When presenting the injection series in a demand package, include the physician's notes from each post-injection follow-up. The duration of pain relief after each injection — and the eventual return of symptoms — creates a powerful narrative of persistent injury that the defense cannot dismiss.

Oral Medications That Accompany Injection Series

Corticosteroid injections do not replace oral medication therapy — they supplement it. The pharmacy lien typically includes medications prescribed alongside the injection series:

Before injections: NSAIDs, muscle relaxants, and neuropathic pain agents prescribed when oral therapy alone was the treatment approach.

Between injections: Breakthrough pain medications prescribed for symptom management during the intervals between injections. These medications document that even with injection therapy, the patient requires additional pain control.

After the injection series: If injections provide only temporary relief, the physician may add new oral medications or increase existing doses, further documenting the severity and persistence of the injury.

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "The pharmacy lien captures the complete medication picture — the oral medications that preceded the injections, the breakthrough medications between injections, and any changes after the injection series. This comprehensive documentation shows the full scope of pharmacological treatment the injury required."

Documenting Injection Costs on the Pharmacy Lien

Corticosteroid medications used in injection procedures (triamcinolone, methylprednisolone, betamethasone) are pharmaceutical products that may appear on the pharmacy lien when dispensed through the lien pharmacy. The medication cost is separate from the procedural cost (which appears on the medical provider's bill).

Key documentation points:

• The specific corticosteroid formulation, concentration, and volume used
• The National Drug Code (NDC) for each injectable product
• The date of dispensing and the administering physician
• The injection site and clinical indication

Adjuster Challenges to Injection Series Documentation

"The injections were unnecessary — oral medications should have been sufficient."

Response: The treating physician determined that oral medications were insufficient to control the patient's pain, which is why the injection series was prescribed. This escalation from oral to injectable therapy documents the severity of the condition and the failure of less invasive treatment.

"Three injections are excessive."

Response: The standard protocol for epidural steroid injections involves a series of up to three injections to achieve maximum therapeutic benefit. Each injection is a separate clinical determination by the treating physician that continued treatment is warranted. The series was performed according to accepted pain management protocols.

"The injections only provided temporary relief, so they were not effective."

Response: Temporary relief that recurs demonstrates both the effectiveness of the treatment and the persistence of the underlying pathology. The injection provided relief — proving that inflammation at the injection site was causing pain — and the return of symptoms proves that the underlying injury has not resolved.

[!KEY] The LienScripts MERIT report documents the clinical relationship between the injection series and the oral medication regimen, providing a pharmacist-authored narrative that explains how each medication component supports the overall pain management strategy for the documented injuries.

Contact LienScripts to learn how pharmacy lien documentation supports injection series cases in demand packages.

Related Resources

• How to Use Pharmacy Records in Your Demand Package
• Pain Management After Car Accident: Pharmacy Lien Guide
• Pharmacy Services for Personal Injury Clients: How It Works